Author
Byong Duk Ye
Also Known As
B D Ye, B Ye, B. D. YE, B. D. Ye, B. Ye, Byong D Ye, Byong Duk Ye, Byong Ye, Byong-Duk Ye, ByongDuk Ye
732
Publications
11.7K
Citations
54
H-Index
112
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 29 | 62 | 2.9K |
2 | Public Health | 3 | 3 | 131 |
3 | Health Sciences | 2 | 2 | 76 |
4 | Engineering | 1 | 1 | 44 |
5 | Allergy | 1 | 1 | 19 |
Byong Duk Ye
×
256
Publications
10K
Citations
53
H-Index
| Year | Citations | |
|---|---|---|
2014 | 535 | |
2021 | 216 | |
Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study Byong Duk Ye, Marina Pesegova, Olga Alexeeva, Biosimilar Ct-p13Originator InfliximabGastroenterologyClinical GastroenterologyUlcerative Colitis | 2019 | 203 |
2013 | 183 | |
2019 | 160 | |
2015 | 147 | |
2010 | 141 | |
2009 | 138 | |
2010 | 109 | |
2007 | 101 |
Page 1
Page 1